Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder

被引:67
作者
Altamura, A. Carlo [1 ]
Dell'Osso, Bernardo [1 ]
D'Urso, Nazario [1 ]
Russo, Michela [2 ]
Fumagalli, Sara [2 ]
Mundo, Emanuela [1 ]
机构
[1] Univ Milan, Fdn IRCCS, Dept Psychiat, Psychiat Unit,Osped Maggiore Policlin, I-20122 Milan, Italy
[2] Univ Milan, Dept Clin Sci Luigi Sacco, I-20122 Milan, Italy
关键词
D O I
10.1017/S1092852900016588
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The aim of the present study was to investigate the impact of the duration of untreated illness (DUI)-defined as the time elapsing between the onset of generalized anxiety disorder (GAD) and the first adequate pharmacologic treatment-on treatment response and clinical course in a sample of subjects with GAD. Methods: One hundred patients with GAD, diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision criteria, were enrolled and their main demographic and clinical features collected. Patients were then treated with selective serotonin reuptake inhibitors or venlafaxine for 8 weeks in open-label conditions. Treatment response and other clinical variables were analyzed after dividing the sample into two groups according to DUI (DUI <= 12 months and DUI > 12 months). Results: When the DUI was computed with respect to the first antidepressant treatment (DUI-AD), a higher improvement (Clinical Global Impressions-Severity of Illness scale) after the pharmacologic treatment was found in the group with a shorter DUI (analysis of variance with repeated measures: time effect F=654.975, P <.001; group effect: F=4.369, P=.039). When computed with respect to the first treatment with benzodiazepines (DUI-BDZ), the two groups did not show any significant difference in treatment response (time effect: F=652.183, P <.001; group effect: F=0.009, P=.924). In addition, patients with a longer DUI (DUI-BDZ or DUI-AD) showed an earlier age at onset, a longer duration of illness and a higher rate of comorbid psychiatric disorders with onset later than GAD. Conclusion: Results from this preliminary study seem to suggest that a shorter DUI-AD may determine a better response to pharmacologic treatment in patients with GAD, and that a longer DUI (DUI-BDZ and DUI-AD) may be associated to a worse clinical course. Further investigation on the relationship between DUI and GAD is needed.
引用
收藏
页码:415 / 422
页数:8
相关论文
共 30 条
[21]   Selective reduction in amygdala volume in pediatric anxiety disorders: A voxel-based morphometry investigation [J].
Milham, MP ;
Nugent, AC ;
Drevets, WC ;
Dickstein, DP ;
Leibenluft, E ;
Ernst, M ;
Charney, D ;
Pine, DS .
BIOLOGICAL PSYCHIATRY, 2005, 57 (09) :961-966
[22]  
MUNDO E, 2005, ANN M AM PSYCH ASS M
[23]  
Ninan PT, 2001, J CLIN PSYCHIAT, V62, P5
[24]   Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis [J].
Perkins, DO ;
Gu, HB ;
Boteva, K ;
Lieberman, JA .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (10) :1785-1804
[25]   Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: A pooled analysis of short- and long-term studies [J].
Pollack, MH ;
Meoni, P ;
Otto, MW ;
Hackett, D .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (03) :250-259
[26]   Remission of generalized anxiety disorder: A review of the paroxetine clinical trials database [J].
Rickels, K ;
Rynn, M ;
Iyengar, M ;
Duff, D .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) :41-47
[27]   Generalized anxiety disorder: Acute and chronic treatment [J].
Rynn, MA ;
Brawman-Mintzer, O .
CNS SPECTRUMS, 2004, 9 (10) :716-723
[28]   Perceived barriers to mental health service utilization in the United States, Ontario, and the Netherlands [J].
Sareen, Jitender ;
Jagdeo, Amit ;
Cox, Brian J. ;
Clara, Ian ;
ten Have, Margreet ;
Belik, Shay-Lee ;
de Graaf, Ron ;
Stein, Murray B. .
PSYCHIATRIC SERVICES, 2007, 58 (03) :357-364
[29]   Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER [J].
Stahl, Stephen M. ;
Ahmed, Saeeduddin ;
Haudiquet, Vincent .
CNS SPECTRUMS, 2007, 12 (09) :703-711
[30]  
Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24